RS50495B - Postupak za pripremanje preparata u obliku praha - Google Patents

Postupak za pripremanje preparata u obliku praha

Info

Publication number
RS50495B
RS50495B YUP-274/03A YUP27403A RS50495B RS 50495 B RS50495 B RS 50495B YU P27403 A YUP27403 A YU P27403A RS 50495 B RS50495 B RS 50495B
Authority
RS
Serbia
Prior art keywords
distribution
substance
proportions
substances
layers
Prior art date
Application number
YUP-274/03A
Other languages
English (en)
Inventor
Georg Böck
Michael Walz
Original Assignee
Boehringer Ingelheim Pharma Gmbh. & Co.Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26007343&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS50495(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE2001138022 external-priority patent/DE10138022A1/de
Application filed by Boehringer Ingelheim Pharma Gmbh. & Co.Kg. filed Critical Boehringer Ingelheim Pharma Gmbh. & Co.Kg.
Publication of YU27403A publication Critical patent/YU27403A/sh
Publication of RS50495B publication Critical patent/RS50495B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)

Abstract

Postupak za pripremanje inhalacionih prahova, naznačen time, što se naizmenično, u slojevima, u pogodnu posudu za mešanje, unosi, N+m udela približno istih veličina, supstance sa raspodelom čestica veće veličine (pomoćna supstanca), i N udela istih veličina, supstance sa raspodelom čestica manje veličine (delotvorna supstanca), pa se posle završetka dodavanja 2N+m slojeva, obeju komponenata, one mešaju pomoću odgovarajućeg mešača, pri čemu se prvo dodaje udeo supstance sa raspodelom čestica veće veličine, pri čemu N označava ceo broj > 0, prvenstveno > 5, a pri čemu m označava 0 ili 1. Prijava sadrži još 8 patentnih zahteva.
YUP-274/03A 2000-10-12 2001-10-09 Postupak za pripremanje preparata u obliku praha RS50495B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10050635 2000-10-12
DE2001138022 DE10138022A1 (de) 2001-08-10 2001-08-10 Verfahren zur Herstellung von Pulverformulierungen

Publications (2)

Publication Number Publication Date
YU27403A YU27403A (sh) 2006-03-03
RS50495B true RS50495B (sr) 2010-03-02

Family

ID=26007343

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-274/03A RS50495B (sr) 2000-10-12 2001-10-09 Postupak za pripremanje preparata u obliku praha

Country Status (40)

Country Link
US (2) US6585959B2 (sr)
EP (1) EP1326585B2 (sr)
JP (2) JP4986369B2 (sr)
KR (1) KR100849837B1 (sr)
CN (1) CN1269470C (sr)
AR (1) AR034166A1 (sr)
AT (1) ATE319422T1 (sr)
AU (2) AU1822002A (sr)
BG (1) BG66194B1 (sr)
BR (1) BR0114316A (sr)
CA (1) CA2425005C (sr)
CY (1) CY1105037T1 (sr)
CZ (1) CZ300022B6 (sr)
DE (1) DE50109178D1 (sr)
DK (1) DK1326585T4 (sr)
EA (1) EA004689B1 (sr)
EE (1) EE05146B1 (sr)
EG (1) EG24478A (sr)
ES (1) ES2259046T5 (sr)
HK (1) HK1060522A1 (sr)
HR (1) HRP20030277B1 (sr)
HU (1) HU229512B1 (sr)
IL (2) IL154919A0 (sr)
ME (1) ME02762B (sr)
MX (1) MXPA03003219A (sr)
MY (1) MY155912A (sr)
NO (1) NO333719B1 (sr)
NZ (1) NZ525781A (sr)
PE (1) PE20020424A1 (sr)
PL (1) PL204733B1 (sr)
PT (1) PT1326585E (sr)
RS (1) RS50495B (sr)
SA (1) SA01220518B1 (sr)
SI (1) SI1326585T2 (sr)
SK (1) SK285841B6 (sr)
TW (1) TWI283180B (sr)
UA (1) UA75375C2 (sr)
UY (1) UY26960A1 (sr)
WO (1) WO2002030390A2 (sr)
ZA (1) ZA200301349B (sr)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1210017C (zh) * 2000-10-12 2005-07-13 贝林格尔英格海姆法玛两合公司 含噻托品鎓的新颖可吸入粉末
US6443152B1 (en) * 2001-01-12 2002-09-03 Becton Dickinson And Company Medicament respiratory delivery device
WO2002096422A2 (en) * 2001-05-25 2002-12-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Combination of a dopamine d2-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
US20030070679A1 (en) * 2001-06-01 2003-04-17 Boehringer Ingelheim Pharma Kg Capsules containing inhalable tiotropium
US20030008001A1 (en) * 2001-06-13 2003-01-09 Boehringer Ingelheim Pharma Kg Process for cleaning hard gelatine capsules
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
DE10141376A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Inhalationspulvern
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
US7309707B2 (en) * 2002-03-20 2007-12-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
US7244415B2 (en) * 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
DE60308497T2 (de) * 2002-04-04 2007-02-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverzubereitungen zur inhalation
JP4744876B2 (ja) * 2002-08-21 2011-08-10 ノートン・ヘルスケアー リミテッド 乾燥粉末吸入組成物の製造方法
GB0219513D0 (en) 2002-08-21 2002-10-02 Norton Healthcare Ltd Inhalation compositions including coarse carrier
US20050158248A1 (en) * 2002-08-21 2005-07-21 Xian-Ming Zeng Method of preparing dry powder inhalation compositions
AU2003269989B8 (en) * 2002-08-21 2009-11-12 Norton Healthcare Ltd. Inhalation composition
GB0219511D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
DE10255387A1 (de) * 2002-11-28 2004-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Tiotropium-haltige Pulverformulierung für die Inhalation
DE10351663A1 (de) * 2002-12-20 2004-07-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverförmige Arzneimittel enthaltend ein Tiotropiumsalz und Salmeterolxinafoat
DE10317461A1 (de) 2003-04-16 2004-10-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
US20040226556A1 (en) 2003-05-13 2004-11-18 Deem Mark E. Apparatus for treating asthma using neurotoxin
DE10331350A1 (de) * 2003-07-11 2005-01-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverformulierungen für die Inhalation enthaltend ein neues Anticholinergikum
US7462367B2 (en) 2003-07-11 2008-12-09 Boehringer Ingelheim International Gmbh Anticholinergic powder formulations for inhalation
ATE498394T1 (de) 2003-09-02 2011-03-15 Norton Healthcare Ltd Verfahren zur herstellung eines medikaments
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
UY28589A1 (es) 2003-11-03 2005-06-30 Boehringer Ingelheim Int Nuevas sales de tiotropio, procedimientos para su preparación , así como formulaciones medicamentosas que las contienen
PT1682541E (pt) 2003-11-03 2010-04-14 Boehringer Ingelheim Int Processo para a preparação de sais de tiotrópio
EP1691783B1 (en) * 2003-12-03 2009-11-25 Boehringer Ingelheim International GmbH Pre-metered dry powder inhaler for moisture-sensitive medicaments
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
CN104177448A (zh) 2005-02-10 2014-12-03 葛兰素集团有限公司 使用预分选技术制备乳糖的方法以及由此形成的药物制剂
GB0507835D0 (en) * 2005-04-18 2005-05-25 Solexa Ltd Method and device for nucleic acid sequencing using a planar wave guide
ES2393794T3 (es) 2005-05-02 2012-12-28 Boehringer Ingelheim International Gmbh Nuevas formas cristalinas de bromuro de tiotropio
DE102005059602A1 (de) 2005-12-14 2007-06-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Mikronisierung
EP2011538B1 (en) 2007-07-06 2016-02-17 Vectura Delivery Devices Limited Inhaler
WO2009016133A1 (en) * 2007-07-27 2009-02-05 Cargill, Incorporated Micronization of polyols
EP2082767A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082768A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082766A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Blister Strip Coil Forming
EP2082771A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082772A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
AU2009244058B2 (en) 2008-05-09 2015-07-02 Nuvaira, Inc Systems, assemblies, and methods for treating a bronchial tree
US8298616B2 (en) * 2008-07-24 2012-10-30 American Air Liquide, Inc. Heteroleptic cyclopentadienyl transition metal precursors for deposition of transition metal-containing films
TWI491416B (zh) 2008-12-24 2015-07-11 Daiichi Sankyo Co Ltd 吸入用乾燥粉末醫藥組成物
GB0918450D0 (en) 2009-10-21 2009-12-09 Innovata Ltd Composition
EP2493408B1 (en) 2009-10-27 2015-06-24 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
AU2010319477A1 (en) 2009-11-11 2012-05-24 Holaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
WO2011152804A2 (en) 2010-06-03 2011-12-08 Mahmut Bilgic Process for dry powder formulations
TR201007251A2 (tr) * 2010-09-01 2012-03-21 Bi̇lgi̇ç Mahmut Kalsiyum kanal blokörü formülasyonu.
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
EP3166641B1 (en) 2014-07-09 2018-09-12 Arven Ilac Sanayi Ve Ticaret A.S. A process for the preparation of formulations for inhalation
EP3175842B1 (en) 2015-12-03 2019-12-11 Alfred E. Tiefenbacher (GmbH & Co. KG) Dry powder mixing process
EP3826620A4 (en) * 2018-07-12 2023-03-08 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi INHALATION COMPOSITIONS CONTAINING DOPAMINE GONISTS
WO2022146255A1 (en) * 2020-12-31 2022-07-07 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi A process for the preparation of dry powder compositions for inhalation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242211A (en) 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
US3860618A (en) 1967-08-08 1975-01-14 Philip Saxton Hartley Chromone
US3957965A (en) 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
BE891013A (fr) † 1980-11-05 1982-05-05 Fisons Ltd Compositions pharmaceutique
JPS60150823A (ja) * 1984-01-17 1985-08-08 Satake Eng Co Ltd 穀物混合装置
JPH0439388A (ja) * 1990-06-04 1992-02-10 Teijin Ltd 土砂と繊維状物との混合方法
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
JPH06198156A (ja) * 1993-01-06 1994-07-19 Nagasaki Pref Gov 噴霧積層混合器
IS1796B (is) * 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (de) * 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
PT1283036E (pt) 1998-11-13 2008-03-06 Jagotec Ag Inalador de pó seco de dose múltipla com um reservatório de pó
GB9902689D0 (en) 1999-02-08 1999-03-31 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
DK1326585T4 (da) 2011-01-10
NO20031692D0 (no) 2003-04-11
KR100849837B1 (ko) 2008-08-01
EP1326585B2 (de) 2010-09-29
MEP42708A (en) 2011-02-10
JP4986369B2 (ja) 2012-07-25
EG24478A (en) 2009-08-03
AU1822002A (en) 2002-04-22
ATE319422T1 (de) 2006-03-15
MY155912A (en) 2015-12-15
SK285841B6 (sk) 2007-09-06
ES2259046T5 (es) 2011-02-28
NZ525781A (en) 2004-11-26
IL154919A0 (en) 2003-10-31
YU27403A (sh) 2006-03-03
WO2002030390A2 (de) 2002-04-18
HRP20030277B1 (en) 2011-09-30
BG107673A (bg) 2003-11-28
HRP20030277A2 (en) 2005-02-28
JP2009197025A (ja) 2009-09-03
SI1326585T1 (sl) 2006-06-30
BR0114316A (pt) 2003-08-26
NO333719B1 (no) 2013-09-02
NO20031692L (no) 2003-06-06
PL204733B1 (pl) 2010-02-26
US6585959B2 (en) 2003-07-01
EA200300429A1 (ru) 2003-10-30
CY1105037T1 (el) 2010-03-03
AR034166A1 (es) 2004-02-04
IL154919A (en) 2011-01-31
EP1326585B1 (de) 2006-03-08
AU2002218220B2 (en) 2006-06-15
MXPA03003219A (es) 2004-12-03
ME02762B (me) 2011-05-10
TWI283180B (en) 2007-07-01
US20020106332A1 (en) 2002-08-08
HK1060522A1 (en) 2004-08-13
EE200300170A (et) 2003-06-16
ZA200301349B (en) 2004-06-30
CN1269470C (zh) 2006-08-16
PL362511A1 (en) 2004-11-02
UA75375C2 (en) 2006-04-17
KR20030051706A (ko) 2003-06-25
CA2425005C (en) 2008-08-05
HUP0301268A3 (en) 2005-05-30
BG66194B1 (bg) 2012-01-31
HU229512B1 (en) 2014-01-28
SK4372003A3 (en) 2003-07-01
EP1326585A2 (de) 2003-07-16
EA004689B1 (ru) 2004-06-24
EE05146B1 (et) 2009-04-15
ES2259046T3 (es) 2006-09-16
JP2004510806A (ja) 2004-04-08
CN1469733A (zh) 2004-01-21
DE50109178D1 (de) 2006-05-04
PE20020424A1 (es) 2002-07-02
DK1326585T3 (da) 2006-05-22
CA2425005A1 (en) 2003-04-04
USRE38912E1 (en) 2005-12-06
SA01220518B1 (ar) 2006-12-10
PT1326585E (pt) 2006-05-31
WO2002030390A3 (de) 2002-06-27
SI1326585T2 (sl) 2011-01-31
HUP0301268A2 (hu) 2003-10-28
UY26960A1 (es) 2002-06-20
CZ300022B6 (cs) 2009-01-14

Similar Documents

Publication Publication Date Title
RS50495B (sr) Postupak za pripremanje preparata u obliku praha
EP2357045A3 (en) Method of manufacturing an electrode
BR0112903A (pt) Pó eletrostático
DE60137452D1 (de) Pulverzubereitungen und verfahren zu ihrer herstellung
HUP9901570A2 (hu) Nanodiszperziók alkalmazása gyógyszerkészítményekben
MXPA03007053A (es) Suspension de cemento de muy baja densidad.
DE69706988D1 (de) Verfahren zur lieferung von zusammensetzungen aus dichten teilchen zur anwendung in transdermale teilchen abgabe
NZ569012A (en) Powder compositions for inhalation comprising a force-controlling agent
AUPQ573300A0 (en) Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
ATE302661T1 (de) Seltenerdlegierungspulver auf eisenbasis und das seltenerdlegierungspulver enthaltende zusammensetzung sowie diese verwendender dauermagnet
PL331715A1 (en) Composition containing microparticles of water-insoluble substances and ethod of obtaining such compositions
FI943923A (fi) Selluloosaeetterien hiukkaskokojakauman vaikutus koostumusten maistuvuuteen
GB9803448D0 (en) Pharmaceutical formulation
NZ502840A (en) High pressure homogenisation method of preparing pharmaceutical compositions of lipid particles comprising a lipid agent and a protein
JP2005510442A5 (sr)
CY1113221T1 (el) Διεργασια για την παρασκευη ενος φαρμακου
DE50000822D1 (de) Verfahren zur herstellung von hartmetallmischungen
MXPA04000211A (es) Granulados que contienen substancias liposolubles y un proceso para la preparacion de los mismos.
ES2171110A1 (es) Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion.
MY147740A (en) Process for the preparation of a pesticidal formulation
TH55574B (th) ยาผงที่สูดดมได้ชนิดใหม่ซึ่งมีไทโอโทรเพียม
AU2003222445A1 (en) Synergistic hepatoprotective composition and a method thereof
CN108862501A (zh) 一种羟乙基纤维素氧化石墨烯絮凝助剂及其制备方法与应用
YU49073B (sh) Postupak za dobijanje antitoksičnog probiotičkog preparata
SE9101027A (sr)